4-[(6-chloropyridin-3-yl)methyl]morpholine,
311774-34-2,
4-((6-Chloropyridin-3-yl)methyl)morpholine,
4-[(6-chloro-3-pyridinyl)methyl]morpholine,
4-((6-CHLORO-3-PYRIDINYL)METHYL)MORPHOLINE,
Bionet2_001631,
AC1MU7OT,
AC1Q3KTK,
Morpholine, 4-[(6-chloro-3-pyridinyl)methyl]-,
SCHEMBL392531,
CTK6H1442,
DTXSID00394259,
SGGCJTJHZSXKJT-UHFFFAOYSA-N,
HMS1368M03,
ALBB-008883,
KS-00001T7J,
9846AD,
BBL012521,
MFCD00684829,
STK501621,
ZINC19283156,
AKOS000154837,
ACN-054438,
MCULE-3566387977,
RTR-060850,
AJ-72805,
SC-32685,
ST069057,
4-[(6-chloro-3-pyridyl)methyl]morpholine,
TR-060850,
4-(6-Chloro-pyridin-3-ylmethyl)-morpholine,
BB 0254785,
4-(6-chloro-pyridin-3-yl-methyl)-morpholine,
EN300-30650,
W-7478,
SR-01000516153,
12W-0842,
SR-01000516153-1,
C10H13ClN2O,
CID3614045,
3-[(2-methylbutanoyl)amino]benzoic acid,
N/A,